Institutions / Kalehua Capital Management LLC
Kalehua Capital Management LLC
CIK 2106181 · Institution · as of Dec 31, 2025
Portfolio value
$101.10M
Positions
19
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Alpha Architect 1-3 Month Box Etf | $26.56M | 26.3% |
| X4 Pharmaceuticals, Inc | $14.89M | 14.7% |
| Sionna Therapeutics, Inc. | $8.11M | 8.0% |
| Relay Therapeutics, Inc. | $7.63M | 7.5% |
| COMPASS Pathways plcCMPS | $5.66M | 5.6% |
| Pharvaris N.V. | $5.52M | 5.5% |
| Septerna, Inc.SEPN | $5.42M | 5.4% |
| Oruka Therapeutics, Inc. | $3.59M | 3.6% |
| Inhibikase Therapeutics, Inc. | $3.59M | 3.5% |
| Allogene Therapeutics, Inc. | $3.49M | 3.5% |
| LeonaBio, Inc.LONA | $2.98M | 2.9% |
| MoonLake ImmunotherapeuticsMLTX | $2.32M | 2.3% |
| Oric Pharmaceuticals, Inc. | $2.18M | 2.2% |
| Verrica Pharmaceuticals Inc.VRCA | $1.96M | 1.9% |
| Tyra Biosciences, Inc. | $1.96M | 1.9% |
| Surrozen, Inc./DESRZN | $1.89M | 1.9% |
| Tenaya Therapeutics, Inc.TNYA | $1.42M | 1.4% |
| Kalaris Therapeutics, Inc.KLRS | $1.18M | 1.2% |
| DiaMedica Therapeutics Inc.DMAC | $759.1K | 0.8% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.